Racial differences in the limb skeletal muscle transcriptional programs of patients with critical limb ischemia

Zoe S Terwilliger1,2, Terence E Ryan3, Emma J Goldberg1,2

  • 1Diabetes and Obesity Institute, East Carolina University, Brody Medical Center, Greenville, NC, USA.

Insights

Critical limb ischemia (CLI), a severe peripheral artery disease (PAD) complication, affects Black individuals disproportionately. This study found common and race-unique molecular changes in CLI limb muscle, offering therapeutic targets.

Area of Science:

  • Molecular biology
  • Genomics
  • Vascular biology

Background:

  • Critical limb ischemia (CLI) is the most severe form of peripheral artery disease (PAD), leading to high morbidity and mortality.
  • Black individuals experience a disproportionately higher incidence of CLI, necessitating research into underlying causes and tailored treatments.

Purpose of the Study:

  • To investigate the molecular differences and similarities in limb muscle tissue between Black and White patients with CLI.
  • To identify potential therapeutic targets for personalized treatment strategies in CLI patients.

Main Methods:

  • Whole transcriptome shotgun sequencing (WTSS) was performed on gastrocnemius muscle from White and Black healthy volunteers and CLI patients.
  • Enrichment analysis identified altered Reactome pathways.
  • Quantitative reverse transcription polymerase chain reaction (RT-qPCR) validated key gene expression changes.

Main Results:

  • Both White and Black CLI patients showed similar reductions in nuclear and mitochondrial genes and oxygen consumption, indicating a shared bioenergetic deficit.
  • Unique alterations in Black CLI patients included changes in hemostasis, extracellular matrix organization, platelet regulation, and vascular wall interactions.
  • Specific genes like MMP9, NUDT4P1, and GRIK2 showed unique expression patterns in Black patients' limb muscles.

Conclusions:

  • CLI shares common molecular pathways across racial groups, primarily related to bioenergetic deficits.
  • Distinct molecular signatures exist in the limb muscles of Black CLI patients, highlighting potential targets for race-specific therapies.
  • This research is a foundational step towards developing personalized therapeutic options for CLI patients.